IP Library Assignment 066978/0082
Patent Assignment
Reel/Frame 066978/0082

Change of Name

Recorded: 2024-04-02 Pages: 5
Assignor
LENZ THERAPEUTICS, INC.
Executed: 2024-03-21
Assignee
LENZ THERAPEUTICS OPERATIONS, INC.
445 MARINE VIEW AVE STE 320, DEL MAR, CALIFORNIA, 92014
Covered Properties (42)
Compositions and Methods for the Treatment of Presbyopia
Patent: 9,089,562 →
Application: 14/223,639 →
Publication: US 2015/0065511
Storage Stable Compositions and Methods for the Treatment of Refractive Errors of the Eye
Patent: 9,320,709 →
Application: 14/742,903 →
Publication: US 2015/0290125
Compositions and Methods for the Treatment of Presbyopia
Patent: 9,844,537 →
Application: 15/073,089 →
Publication: US 2016/0193193
Compositions and Methods for the Improvement of Distance Vision and the Treatment of Refractive Errors of the Eye
Patent: 9,314,427 →
Application: 14/742,921 →
Publication: US 2015/0290126
Compositions and Methods for the Treatment of Presbyopia
Patent: 9,968,594 →
Application: 14/860,770 →
Publication: US 2016/0008337
Compositions and Methods for the Treatment of Presbyopia
Application: 14/860,777 →
Publication: US 2016/0008278
Compositions and Methods for the Treatment of Presbyopia
Patent: 9,833,441 →
Application: 15/073,139 →
Publication: US 2016/0193194
Compositions and Methods for the Treatment of Presbyopia
Application: 17/502,066 →
Publication: US 2022/0031608
Compositions and Methods for the Treatment of Presbyopia
Application: 16/747,070 →
Publication: US 2020/0146976
Compositions and Methods for the Treatment of Presbyopia
Application: 15/235,431 →
Publication: US 2016/0346259
Compositions and Methods for the Treatment of Presbyopia
Application: 15/864,703 →
Publication: US 2018/0140708
Compositions and Methods for the Treatment of Presbyopia
Application: 16/106,730 →
Publication: US 2019/0000755
Compositions and Methods for the Treatment of Presbyopia
Application: 16/881,570 →
Publication: US 2020/0281906
Compositions and Methods for the Treatment of Presbyopia
Application: 17/715,369 →
Publication: US 2022/0233434
Methods for the Treatment of Presbyopia
Application: 18/301,361 →
Publication: US 2023/0248644
Compositions and Methods for the Treatment of Presbyopia
Application: 18/239,045 →
Publication: US 2023/0398064
Compositions and Methods for the Treatment of Presbyopia
Application: 18/465,918 →
Publication: US 2023/0414494
Compositions and Methods for the Treatment of Presbyopia
Application: 18/241,733 →
Publication: US 2023/0404912
Contact Lens Compositions and Methods for the Treatment of Presbyopia
Application: 15/956,931 →
Publication: US 2018/0280363
Methods for the Treatment of Myopia
Application: 16/796,364 →
Publication: US 2020/0188369
Prodrugs of Quinuclidine Ring-containing Muscarinic Agonists and Compositions and Methods Thereof
Application: 16/700,088 →
Publication: US 2020/0181136
Compositions and Methods for the Treatment of Presbyopia
Application: 16/595,789 →
Publication: US 2020/0115377
Compositions and Methods for the Treatment of Presbyopia
Application: 17/069,155 →
Publication: US 2021/0038574
Compositions and Methods for Storage Stable Ophthalmic Drugs
Application: 18/239,087 →
Publication: US 2023/0414587
Method of Reducing Brow Ache
Application: 17/730,376 →
Publication: US 2022/0347170
Compositions and Methods for the Treatment of Presbyopia
Application: 17/552,654 →
Compositions and Methods for the Treatment of Presbyopia
Application: 18/075,720 →
Publication: US 2023/0190739
Compositions and Methods for the Treatment of Eye Conditions
Application: 18/301,510 →
Publication: US 2023/0310392
Compositions and Methods for the Treatment of Presbyopia
Application: 18/239,072 →
Publication: US 2023/0398113
Aceclidine Derivatives, Compositions Thereof and Methods of Use Thereof
Application: 17/988,366 →
Publication: US 2023/0151000
Compositions and Methods for Storage Stable Ophthalmic Drugs
Application: 18/369,737 →
Publication: US 2024/0091207
Compositions and Methods for the Treatment of Presbyopia
Application: 61/882,998 →
Compositions and Methods for the Treatment of Presbyopia
Application: 61/904,510 →
Compositions and Methods for the Treatment of Presbyopia
Application: 61/917,620 →
Compositions and Methods for the Treatment of Presbyopia
Application: 61/938,438 →
Prodrugs of Quinuclidine Ring-containing Muscarinic Agonists and Compositions and Methods Thereof
Application: 62/775,425 →
Compositions and Methods for the Treatment of Presbyopia
Application: 62/743,720 →
Method of Reducing Brow Ache
Application: 63/180,691 →
Aceclidine Derivatives, Compositions Thereof and Methods of Use Thereof
Application: 63/280,228 →
Contact Lens Compositions and Methods for the Treatment of Presbyopia
Application: 16/385,107 →
Publication: US 2019/0240152
Compositions and Methods for Storage Stable Ophthalmic Drugs
Application: 17/242,398 →
Publication: US 2021/0251970
Compositions and Methods for the Treatment of Eye Conditions
Application: 17/552,622 →
Publication: US 2023/0190738
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 25, 2014
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 032516/0897 →
Assignment of Assignor's Interest Nov 10, 2015
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 037001/0001 →
Assignment of Assignor's Interest Jun 5, 2020
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES, LLC
Reel/Frame 052849/0632 →
Change of Name Nov 9, 2020
From: PRESBYOPIA THERAPIES, LLC
To: PRESBYOPIA THERAPIES, INC.
Reel/Frame 054363/0516 →
Merger and Change of Name Sep 29, 2021
From: PRESBYOPIA THERAPIES, INC.; PRESBYOPIA THERAPIES, INC.
To: LENZ THERAPEUTICS, INC.
Reel/Frame 057671/0014 →
Change of Name Apr 21, 2022
From: PRESBYOPIA THERAPIES, INC.
To: LENZ THERAPEUTICS, INC.
Reel/Frame 059750/0492 →
Assignment of Assignor's Interest Apr 21, 2022
From: HORN, GERALD
To: PRESBYOPIA THERAPIES, LLC
Reel/Frame 059668/0780 →
Change of Name Apr 21, 2022
From: PRESBYOPIA THERAPIES, LLC
To: PRESBYOPIA THERAPIES, INC.
Reel/Frame 059750/0489 →
Assignment of Assignor's Interest Dec 15, 2022
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 062110/0738 →
Change of Name Dec 15, 2022
From: PRESBYOPIA THERAPIES, LLC
To: PRESBYOPIA THERAPIES, INC.
Reel/Frame 062138/0419 →
Change of Name Dec 15, 2022
From: PRESBYOPIA THERAPIES, INC.
To: LENZ THERAPEUTICS, INC.
Reel/Frame 062138/0441 →
Change of Name Dec 15, 2022
From: PRESBYOPIA THERAPIES, INC.
To: LENZ THERAPEUTICS, INC.
Reel/Frame 062138/0206 →
Corrective Assignment to Correct the Application Number 17562694 Previously Recorded at Reel: 062110 Frame: 0738. Assignor(S) Hereby Confirms the Assignment . Dec 19, 2022
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 062155/0144 →
Assignment of Assignor's Interest Dec 13, 2023
From: HORN, GERALD
To: LENZ THERAPEUTICS, INC.
Reel/Frame 065856/0477 →
Assignment of Assignor's Interest Dec 13, 2023
From: HORN, GERALD
To: LENZ THERAPEUTICS, INC.
Reel/Frame 065856/0282 →
Assignment of Assignor's Interest Dec 13, 2023
From: HORN, GERALD
To: LENZ THERAPEUTICS, INC.
Reel/Frame 065857/0144 →
Assignment of Assignor's Interest Dec 13, 2023
From: HORN, GERALD
To: LENZ THERAPEUTICS, INC.
Reel/Frame 065857/0227 →